UNION CITY, Calif., July 19, 2011 /PRNewswire/ — Abaxis, Inc.
(NasdaqGS: ABAX), a medical products company manufacturing
point-of-care blood analysis systems, has scheduled a conference
call to discuss its financial results for the first quarter of
fiscal year 2012, ended June 30, 2011. The call will be at 4:15
p.m. ET on Thursday, July 28, 2011. The Company will report
financial results for the first quarter of fiscal year 2012 after
the market closes on Thursday, July 28, 2011.
Participants can dial (877) 317-6789 or (412) 317-6789 to access
the conference call, or can listen via a live Internet web cast,
which is available in the Investor Relations section of the
Company’s website at www.abaxis.com. A replay of the
call is available by visiting www.abaxis.com for the next 30
days or by calling (877) 344-7529 or (412) 317-0088, confirmation
code 10002131, through August 3, 2011.
About AbaxisAbaxis develops, manufactures and markets
portable blood analysis systems for use in any veterinary or human
patient-care setting to provide clinicians with rapid blood
constituent measurements. The system consists of a compact, 5.1
kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs or rotors, which
contain all the chemicals required to perform a panel of up to 13
tests on veterinary patients and 14 tests on human patients. The
system can be operated with minimal training and performs multiple
routine tests on whole blood, serum or plasma samples. The system
provides test results in less than 12 minutes with the precision
and accuracy equivalent to a clinical laboratory analyzer. The
veterinary business also provides to the animal health and research
market a line of hematology instruments for point-of-care complete
blood counts (CBC), a specialty instrument to screen for and detect
clotting disorders and to measure equine fi
‘/>”/>
